IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.759
NA - Nord America 3.038
EU - Europa 1.536
AF - Africa 68
SA - Sud America 66
OC - Oceania 38
AN - Antartide 1
Totale 15.506
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.559
US - Stati Uniti d'America 2.889
HK - Hong Kong 2.050
CN - Cina 1.803
GB - Regno Unito 605
IT - Italia 269
DE - Germania 211
IN - India 129
CA - Canada 111
NL - Olanda 91
JP - Giappone 60
TR - Turchia 47
UA - Ucraina 47
FR - Francia 46
BR - Brasile 38
PL - Polonia 38
ZA - Sudafrica 38
AU - Australia 37
MX - Messico 37
FI - Finlandia 35
ES - Italia 34
CZ - Repubblica Ceca 24
SE - Svezia 22
PT - Portogallo 17
AT - Austria 16
BD - Bangladesh 16
ID - Indonesia 15
EG - Egitto 12
CL - Cile 9
AR - Argentina 8
IL - Israele 8
KZ - Kazakistan 8
LT - Lituania 8
SA - Arabia Saudita 8
BG - Bulgaria 7
DK - Danimarca 7
IR - Iran 7
PK - Pakistan 7
RO - Romania 7
CH - Svizzera 6
CO - Colombia 5
EE - Estonia 5
GR - Grecia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
JO - Giordania 4
MA - Marocco 4
RU - Federazione Russa 4
SN - Senegal 4
TH - Thailandia 4
VN - Vietnam 4
AL - Albania 3
EC - Ecuador 3
KR - Corea 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
BE - Belgio 2
BO - Bolivia 2
CY - Cipro 2
GH - Ghana 2
HU - Ungheria 2
LV - Lettonia 2
NG - Nigeria 2
PH - Filippine 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
AZ - Azerbaigian 1
BY - Bielorussia 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RW - Ruanda 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
YT - Mayotte 1
ZM - Zambia 1
Totale 15.506
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.028
Hefei 1.100
Singapore 967
Ashburn 830
Boardman 613
London 525
Shanghai 348
Council Bluffs 179
Beijing 170
Dallas 142
Los Angeles 114
Pune 94
San Francisco 90
Amsterdam 66
Munich 61
Toronto 60
Rome 57
Washington 51
Seattle 48
Tokyo 44
Santa Clara 43
New York 35
Warsaw 31
Brooklyn 29
Ankara 25
Montreal 23
Turku 23
Chicago 21
West Jordan 20
Brno 19
Stockholm 19
Bari 17
Boston 17
Johannesburg 17
Guangzhou 16
Manchester 15
Chennai 14
Mexico City 14
Melbourne 13
Jinan 12
Phoenix 12
São Paulo 12
Helsinki 11
Naples 11
Paris 11
Qingdao 11
Barcelos 10
Charlotte 10
Secaucus 10
Sydney 10
Atlanta 9
Hanover 9
Milan 9
Nuremberg 9
The Dalles 9
Canberra 8
Hangzhou 8
Cairo 7
Changsha 7
Frankfurt am Main 7
Jaguariúna 7
Madrid 7
Oklahoma City 7
Las Vegas 6
St Louis 6
Xi'an 6
Andover 5
Bengaluru 5
Berlin 5
Bratislava 5
Brisbane 5
Central 5
Olomouc 5
Ottawa 5
Riyadh 5
Vienna 5
Amman 4
Athens 4
Bangkok 4
Bologna 4
Buffalo 4
Chaozhou 4
Dakar 4
Dhaka 4
Dublin 4
Haikou 4
Jackson 4
Kansas City 4
Kongens Lyngby 4
Markham 4
Nanjing 4
Newark 4
Noicattaro 4
Salerno 4
Shijiazhuang 4
Sofia 4
State College 4
Aberdeen 3
Almaty 3
Belgrade 3
Totale 8.382
Salva come PNG Salva come JPEG
Nome #
------- 211
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 205
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 201
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 197
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 192
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 189
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 181
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 179
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 177
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 168
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 163
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 163
A comprehensive review on adult onset Still's disease 162
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 161
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 158
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 155
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 152
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 149
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 148
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 144
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 135
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 122
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 114
Adult-onset Still's disease with elderly onset: results from a multicentre study 103
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 103
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 96
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 93
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 87
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 85
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 84
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 83
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 83
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 82
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 80
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 78
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 77
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 77
Cytokine storm syndrome in severe COVID-19 76
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 75
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 75
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 75
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 74
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 73
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 72
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 71
Cardiovascular disease in primary sjögren’s syndrome 67
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 66
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 63
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 61
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 56
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 55
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 50
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 50
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 45
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 44
The Vessels Contribute to Fibrosis in Systemic Sclerosis 44
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 43
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 43
The economic burden of fibromyalgia: A systematic literature review 42
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 42
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 40
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 40
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 39
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 38
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 38
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 37
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 37
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 36
Development and implementation of the AIDA International Registry for patients with Behçet's disease 35
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 34
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 34
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 34
Vitamin D and systemic lupus erythematosus - The hype and the hope 33
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 33
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 32
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 32
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 31
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 31
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 31
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 30
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 30
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 30
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 30
Potential of stem cells in the treatment of rheumatic disease 29
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 29
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 29
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 28
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 28
Neoplasie e sistema immune 28
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 28
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects 28
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 27
Vascular complications of scleroderma 27
Interstitial lung disease in systemic sclerosis: current and future treatment. 27
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 27
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 27
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 26
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 26
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 26
IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients 26
Totale 7.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 180.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/20262.037 1.556 481 0 0 0 0 0 0 0 0 0 0
Totale 15.656